Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Catheter Cryoablation Versus Antiarrhythmic Drug as First-Line Therapy of Paroxysmal Atrial Fibrillation

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2016 by Medtronic Atrial Fibrillation Solutions
Information provided by (Responsible Party):
Medtronic Atrial Fibrillation Solutions Identifier:
First received: March 1, 2013
Last updated: July 12, 2016
Last verified: July 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2019
  Estimated Primary Completion Date: November 2019 (Final data collection date for primary outcome measure)